Q Therapeutics

Advanced cellular therapeutics for incurable CNS diseases

Salt Lake City, United States · Founded 2006 · $15.0M raised

Employees
1–10
Founded
2006
Business Model
B2B
Website
qthera.com
Total Funding
$15.0M
Last Round
$15.0M Series BFeb 2008
Rounds
1

About

Q Therapeutics has adopted a unique approach to developing human cell-based therapies for debilitating and currently incurable diseases of the brain and spinal cord, focusing on glial cells that support, repair, and maintain normal neuron function. Its lead candidate, Q-Cells, is a human glial progenitor cell therapy with FDA IND allowance to begin a Phase 1/2a clinical trial in transverse myelitis, a spinal cord condition affecting roughly 40,000 people in the US. Q-Cells are an off-the-shelf, allogeneic therapy requiring no genetic manipulation, isolated and purified from brain tissue to perform natural CNS repair functions.

Summary

Q Therapeutics is a Biotech company based in Salt Lake City, United States, founded in 2006. It has raised $15.0M in total across 1 round, most recently a $15.0M Series B round in Feb 2008. Investors include vSpring Capital and EPIC Ventures.

Tech & App Stack

2 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Series BSeries BFeb 2008
$15.0M

Investors

Similar Companies

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Q Therapeutics on Indexed.vc
<a href="https://indexed.vc/companies/q-therapeutics"><img src="https://indexed.vc/api/badge/company/q-therapeutics" alt="Q Therapeutics on Indexed.vc" width="260" height="76" /></a>